|
(b)(6).Difficulty swallowing began on an unknown date in (b)(6) 2018.Device has not been reported as explanted.Complainant part is not expected to be returned for manufacturer review/investigation.Reporter address and phone number were not available for reporting.The investigation could not be completed; no conclusion could be drawn, as no product was received.A review of the device history records has been requested.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that a patient underwent an anterior cervical discectomy fusion (acdf) procedure at the c4-c7 levels on (b)(6) 2018.The patient was implanted with one (1) vectra 51 mm plate, three (3) 7 mm spacers with central lumen, and one (1) 1 cc vivigen pouch.Postoperatively, on (b)(6) 2018 the patient presented with difficulty swallowing.The patient was treated with a medrol dose pack, and the outcome was reported as recovered/resolved with no residual effects.On (b)(6) 2018, the patient presented with swelling in the neck.Concomitant devices reported: biologic tissue matrix: vivigen (part bl-1500-001, lot 1811149-8027, quantity 1 cc cell bone); 7 mm acf spacer (part 017207, lot 00514025521027, quantity 1); 7 mm acf spacer (part 017207, lot 00514025521028, quantity 1); 7 mm acf spacer (part 017207, lot 00616061301055, quantity 1) this report is to capture the difficulty swallowing.The swelling in the neck will be captured on related (b)(4).This is report 1 of 2 for (b)(4).
|